Solazyme to Present at the 4th Annual Credit Suisse Small & Mid Cap Conference

Updated

Solazyme to Present at the 4th Annual Credit Suisse Small & Mid Cap Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, Inc. (NAS: SZYM) , a renewable oil and bioproducts company, today announced its participation in the 4th Annual Credit Suisse Small & Mid Cap Conference. Details of the company's presentation include:

4thAnnual Credit Suisse Small & Mid Cap Conference


Date: Tuesday, September 17, 2013

Time: 12:50 p.m. PT (3:50 p.m. ET)

Location: The Waldorf Astoria in New York, NY

Speaker: Jonathan Wolfson, Chief Executive Officer

The event sponsor is not making available a webcast of this event.

About Solazyme, Inc.

Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils and food ingredients. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources — petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) chemicals and fuels, (2) nutrition and (3) skin and personal care.

Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.



Solazyme, Inc.
Genet Garamendi
Corporate Communications
press@solazyme.com
or
Brainerd Communicators, Inc.
Jeff Majtyka, 212-986-6667
majtyka@braincomm.com
Brad Edwards, 212-986-6667
edwards@braincomm.com

KEYWORDS: United States North America California New York

INDUSTRY KEYWORDS:

The article Solazyme to Present at the 4th Annual Credit Suisse Small & Mid Cap Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement